Abstract
Dietary interventions can be a powerful tool for prevention and treatment of aging-associated diseases, but the molecular mechanisms through which diet affects health remain underexplored in humans. Here, we compare plasma metabolomic and proteomic profiles between dietary states for a unique group of individuals who alternate between omnivory and restriction of animal products for religious reasons. We find that short-term restriction drives reductions in levels of lipid classes and of branched-chain amino acids, not detected in a control group of individuals, and results in metabolic profiles associated with decreased risk for all-cause mortality and beneficial effects against aging-associated diseases. We show that 23% of restriction-associated proteins are druggable targets and reveal that pro-longevity hormone FGF21 and seven additional proteins (FOLR2, SUMF2, HAVCR1, PLA2G1B, OXT, HPGDS, SPP1) display the greatest magnitude of change upon restriction. Through Mendelian randomization we demonstrate potentially causal effects of FGF21 (P=0.0032) and HAVCR1 (P=4.64e-05) on risk for type 2 diabetes, of HPGDS (P=5.06E-05) on BMI, and of OXT (P=0.00165) on risk for lacunar stroke. Collectively, these findings can inform the development of interventions mimicking molecular responses that promote healthy aging and have positive effects on health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by an ERC grant to Dr Antigone Dimas (FastBio 716998). Dr Ozvan Bocher has received funding from the European Union Horizon 2020 research and innovation programme under Grant Agreement No 101017802 (OPTOMICS).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of BSRC Alexander Fleming gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We updated the main text and supplement for re-submission.
Data Availability
All data produced in the present study are available upon reasonable request to the authors. Proteomics and metabolomics summary statistics are available at Zenodo.
